875 related articles for article (PubMed ID: 29675794)
1. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
Kamamoto D; Ohara K; Kitamura Y; Yoshida K; Kawakami Y; Sasaki H
J Neurooncol; 2018 Sep; 139(2):251-259. PubMed ID: 29675794
[TBL] [Abstract][Full Text] [Related]
2. A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.
Giordan E; Marton E; Wennberg AM; Guerriero A; Canova G
Neurosurg Rev; 2021 Jun; 44(3):1299-1312. PubMed ID: 32556679
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors.
Kim BS; Kim Y; Kong DS; Nam DH; Lee JI; Suh YL; Seol HJ
J Neurosurg; 2018 Dec; 129(6):1384-1396. PubMed ID: 29372881
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease.
Ratneswaren T; Hogg FRA; Gallagher MJ; Ashkan K
J Neurooncol; 2018 Jul; 138(3):447-467. PubMed ID: 29551003
[TBL] [Abstract][Full Text] [Related]
5. Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors.
Zeng L; Wang Y; Wang Y; Han L; Niu H; Zhang M; Ke C; Chen J; Lei T
J Neurooncol; 2017 Jan; 131(1):153-161. PubMed ID: 27671018
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the inflammatory tumor microenvironment in meningeal neoplasms.
Berghoff AS; Kresl P; Rajky O; Widhalm G; Ricken G; Hainfellner JA; Marosi C; Birner P; Preusser M
Clin Neuropathol; 2020; 39(6):256-262. PubMed ID: 32831157
[TBL] [Abstract][Full Text] [Related]
7. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
Lim YJ; Koh J; Kim K; Chie EK; Kim B; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ; Ha SW
Radiother Oncol; 2015 Oct; 117(1):165-70. PubMed ID: 26235847
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
Tomioka N; Azuma M; Ikarashi M; Yamamoto M; Sato M; Watanabe KI; Yamashiro K; Takahashi M
Breast Cancer; 2018 Jan; 25(1):34-42. PubMed ID: 28488168
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.
Liu P; Xiao Q; Zhou B; Dai Z; Kang Y
World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313
[TBL] [Abstract][Full Text] [Related]
12. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.
Harter PN; Bernatz S; Scholz A; Zeiner PS; Zinke J; Kiyose M; Blasel S; Beschorner R; Senft C; Bender B; Ronellenfitsch MW; Wikman H; Glatzel M; Meinhardt M; Juratli TA; Steinbach JP; Plate KH; Wischhusen J; Weide B; Mittelbronn M
Oncotarget; 2015 Dec; 6(38):40836-49. PubMed ID: 26517811
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.
Bösch F; Brüwer K; Altendorf-Hofmann A; Auernhammer CJ; Spitzweg C; Westphalen CB; Boeck S; Schubert-Fritschle G; Werner J; Heinemann V; Kirchner T; Angele M; Knösel T
Endocr Relat Cancer; 2019 Mar; 26(3):293-301. PubMed ID: 30608901
[TBL] [Abstract][Full Text] [Related]
14. A DSTYK mutation activates ERK1/2 signaling to promote intraspinal dissemination in a case of solitary fibrous tumor/hemangiopericytoma.
Tang G; Yang Y; Shang L; Jun F; Liu Q
Lab Invest; 2019 Oct; 99(10):1501-1514. PubMed ID: 31201369
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
[TBL] [Abstract][Full Text] [Related]
16. Programmed Death Ligand 1: A Step Toward Immunoscore for Esophageal Cancer.
Hynes CF; Kwon DH; Vadlamudi C; Lofthus A; Iwamoto A; Chahine JJ; Desale S; Margolis M; Kallakury BV; Watson TJ; Haddad NG; Marshall MB
Ann Thorac Surg; 2018 Oct; 106(4):1002-1007. PubMed ID: 29859152
[TBL] [Abstract][Full Text] [Related]
17. [Solitary fibrous tumor/hemangiopericytoma of central nervous system: a clinicopathologic analysis of 71 cases].
Li XL; Fu WW; Zhang S; Chen DY; Chen YP; Wu J; Liu XY; Li GP; Lin SM; Luo S; Cai SS; Guo W; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):465-470. PubMed ID: 28728219
[No Abstract] [Full Text] [Related]
18. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
19. PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.
Liu B; Arakawa Y; Yokogawa R; Tokunaga S; Terada Y; Murata D; Matsui Y; Fujimoto KI; Fukui N; Tanji M; Mineharu Y; Minamiguchi S; Miyamoto S
PLoS One; 2018; 13(4):e0194594. PubMed ID: 29617441
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of spinal solitary fibrous tumor/hemangiopericytoma: a case series of 20 patients.
Jia Q; Zhou Z; Zhang D; Yang J; Liu C; Wang T; Wu Z; Yang C; Wei H; Zhao J; Liu T; Zhou W; Yang X; Xiao J
Eur Spine J; 2018 Apr; 27(4):891-901. PubMed ID: 29127512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
